nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—CYP2E1—Pilocarpine—glaucoma	0.0196	0.597	CbGbCtD
Dalfampridine—CYP2E1—Methazolamide—glaucoma	0.0132	0.403	CbGbCtD
Dalfampridine—KCNV2—eye—glaucoma	0.00991	0.105	CbGeAlD
Dalfampridine—KCNV2—retina—glaucoma	0.00982	0.104	CbGeAlD
Dalfampridine—KCNB1—eye—glaucoma	0.00816	0.0867	CbGeAlD
Dalfampridine—KCNC3—eye—glaucoma	0.00792	0.0841	CbGeAlD
Dalfampridine—KCNS1—eye—glaucoma	0.00733	0.0778	CbGeAlD
Dalfampridine—KCNQ4—eye—glaucoma	0.00674	0.0715	CbGeAlD
Dalfampridine—KCNQ4—retina—glaucoma	0.00668	0.0709	CbGeAlD
Dalfampridine—KCNQ5—eye—glaucoma	0.00655	0.0696	CbGeAlD
Dalfampridine—KCNQ5—retina—glaucoma	0.0065	0.069	CbGeAlD
Dalfampridine—KCND2—Circadian rythm related genes—ATOH7—glaucoma	0.00593	0.0286	CbGpPWpGaD
Dalfampridine—KCNA5—retina—glaucoma	0.00532	0.0565	CbGeAlD
Dalfampridine—KCNS3—eye—glaucoma	0.00526	0.0558	CbGeAlD
Dalfampridine—KCNH7—Circadian rythm related genes—ATOH7—glaucoma	0.00518	0.025	CbGpPWpGaD
Dalfampridine—KCNA5—connective tissue—glaucoma	0.00518	0.0549	CbGeAlD
Dalfampridine—KCNQ2—eye—glaucoma	0.00484	0.0514	CbGeAlD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00468	0.0226	CbGpPWpGaD
Dalfampridine—KCNA1—retina—glaucoma	0.00398	0.0423	CbGeAlD
Dalfampridine—KCNA3—BDNF signaling pathway—NCK2—glaucoma	0.00304	0.0146	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—OPN4—glaucoma	0.00236	0.0114	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—SLC6A13—glaucoma	0.00215	0.0103	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—OPN4—glaucoma	0.00206	0.00996	CbGpPWpGaD
Dalfampridine—Angioedema—Dorzolamide—glaucoma	0.00199	0.00299	CcSEcCtD
Dalfampridine—Nausea—Metipranolol—glaucoma	0.00199	0.00299	CcSEcCtD
Dalfampridine—Dizziness—Carbachol—glaucoma	0.00197	0.00295	CcSEcCtD
Dalfampridine—Insomnia—Apraclonidine—glaucoma	0.00196	0.00295	CcSEcCtD
Dalfampridine—Confusional state—Acetazolamide—glaucoma	0.00196	0.00294	CcSEcCtD
Dalfampridine—Paraesthesia—Apraclonidine—glaucoma	0.00195	0.00293	CcSEcCtD
Dalfampridine—Chest pain—Brimonidine—glaucoma	0.00194	0.00292	CcSEcCtD
Dalfampridine—Anaphylactic shock—Acetazolamide—glaucoma	0.00194	0.00292	CcSEcCtD
Dalfampridine—Headache—Carteolol—glaucoma	0.00194	0.00292	CcSEcCtD
Dalfampridine—Anxiety—Brimonidine—glaucoma	0.00194	0.00291	CcSEcCtD
Dalfampridine—Vomiting—Diclofenamide—glaucoma	0.00194	0.00291	CcSEcCtD
Dalfampridine—Dizziness—Levobunolol—glaucoma	0.00194	0.00291	CcSEcCtD
Dalfampridine—Dyspnoea—Apraclonidine—glaucoma	0.00194	0.00291	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00193	0.0029	CcSEcCtD
Dalfampridine—Tremor—Pilocarpine—glaucoma	0.00193	0.0029	CcSEcCtD
Dalfampridine—Rash—Diclofenamide—glaucoma	0.00192	0.00289	CcSEcCtD
Dalfampridine—KCNA3—Neuronal System—SLC6A13—glaucoma	0.00191	0.00922	CbGpPWpGaD
Dalfampridine—Headache—Diclofenamide—glaucoma	0.00191	0.00287	CcSEcCtD
Dalfampridine—Insomnia—Bimatoprost—glaucoma	0.0019	0.00286	CcSEcCtD
Dalfampridine—Vomiting—Carbachol—glaucoma	0.00189	0.00284	CcSEcCtD
Dalfampridine—Dyspnoea—Bimatoprost—glaucoma	0.00188	0.00282	CcSEcCtD
Dalfampridine—Rash—Carbachol—glaucoma	0.00188	0.00282	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00187	0.00282	CcSEcCtD
Dalfampridine—Dermatitis—Carbachol—glaucoma	0.00187	0.00281	CcSEcCtD
Dalfampridine—Headache—Carbachol—glaucoma	0.00186	0.0028	CcSEcCtD
Dalfampridine—Chest pain—Dorzolamide—glaucoma	0.00186	0.00279	CcSEcCtD
Dalfampridine—Constipation—Apraclonidine—glaucoma	0.00186	0.00279	CcSEcCtD
Dalfampridine—Dyspepsia—Bimatoprost—glaucoma	0.00185	0.00278	CcSEcCtD
Dalfampridine—Infection—Brimonidine—glaucoma	0.00185	0.00278	CcSEcCtD
Dalfampridine—Anxiety—Dorzolamide—glaucoma	0.00185	0.00278	CcSEcCtD
Dalfampridine—Chest pain—Travoprost—glaucoma	0.00185	0.00278	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—NTRK2—glaucoma	0.00185	0.00891	CbGpPWpGaD
Dalfampridine—Anxiety—Travoprost—glaucoma	0.00184	0.00277	CcSEcCtD
Dalfampridine—Nausea—Carteolol—glaucoma	0.00184	0.00277	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.00184	0.00276	CcSEcCtD
Dalfampridine—Headache—Levobunolol—glaucoma	0.00183	0.00276	CcSEcCtD
Dalfampridine—Infestation NOS—Betaxolol—glaucoma	0.00183	0.00275	CcSEcCtD
Dalfampridine—Infestation—Betaxolol—glaucoma	0.00183	0.00275	CcSEcCtD
Dalfampridine—Nervous system disorder—Brimonidine—glaucoma	0.00183	0.00275	CcSEcCtD
Dalfampridine—Chest pain—Brinzolamide—glaucoma	0.00183	0.00274	CcSEcCtD
Dalfampridine—KCNQ4—Neuronal System—SLC6A13—glaucoma	0.00182	0.0088	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—SLC6A13—glaucoma	0.00182	0.0088	CbGpPWpGaD
Dalfampridine—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00182	0.00273	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.00181	0.00272	CcSEcCtD
Dalfampridine—Skin disorder—Brimonidine—glaucoma	0.00181	0.00272	CcSEcCtD
Dalfampridine—Nausea—Diclofenamide—glaucoma	0.00181	0.00272	CcSEcCtD
Dalfampridine—Dizziness—Latanoprost—glaucoma	0.0018	0.0027	CcSEcCtD
Dalfampridine—Confusional state—Dorzolamide—glaucoma	0.00179	0.0027	CcSEcCtD
Dalfampridine—Feeling abnormal—Apraclonidine—glaucoma	0.00179	0.00269	CcSEcCtD
Dalfampridine—Vomiting—Methazolamide—glaucoma	0.00178	0.00268	CcSEcCtD
Dalfampridine—Anaphylactic shock—Dorzolamide—glaucoma	0.00178	0.00267	CcSEcCtD
Dalfampridine—Rash—Methazolamide—glaucoma	0.00177	0.00266	CcSEcCtD
Dalfampridine—Dermatitis—Methazolamide—glaucoma	0.00177	0.00266	CcSEcCtD
Dalfampridine—Nausea—Carbachol—glaucoma	0.00177	0.00265	CcSEcCtD
Dalfampridine—Infection—Travoprost—glaucoma	0.00176	0.00265	CcSEcCtD
Dalfampridine—Headache—Methazolamide—glaucoma	0.00176	0.00264	CcSEcCtD
Dalfampridine—Chest pain—Pilocarpine—glaucoma	0.00175	0.00264	CcSEcCtD
Dalfampridine—Anxiety—Pilocarpine—glaucoma	0.00175	0.00263	CcSEcCtD
Dalfampridine—Paraesthesia—Acetazolamide—glaucoma	0.00174	0.00262	CcSEcCtD
Dalfampridine—Hypotension—Brimonidine—glaucoma	0.00174	0.00262	CcSEcCtD
Dalfampridine—Nausea—Levobunolol—glaucoma	0.00174	0.00261	CcSEcCtD
Dalfampridine—Infection—Brinzolamide—glaucoma	0.00174	0.00261	CcSEcCtD
Dalfampridine—Nervous system disorder—Travoprost—glaucoma	0.00174	0.00261	CcSEcCtD
Dalfampridine—Nasopharyngitis—Timolol—glaucoma	0.00174	0.00261	CcSEcCtD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00173	0.00836	CbGpPWpGaD
Dalfampridine—Skin disorder—Travoprost—glaucoma	0.00172	0.00259	CcSEcCtD
Dalfampridine—Nervous system disorder—Brinzolamide—glaucoma	0.00172	0.00258	CcSEcCtD
Dalfampridine—Angiopathy—Clonidine—glaucoma	0.00172	0.00258	CcSEcCtD
Dalfampridine—Rash—Latanoprost—glaucoma	0.00171	0.00257	CcSEcCtD
Dalfampridine—Dermatitis—Latanoprost—glaucoma	0.00171	0.00257	CcSEcCtD
Dalfampridine—Dyspepsia—Acetazolamide—glaucoma	0.00171	0.00257	CcSEcCtD
Dalfampridine—Mediastinal disorder—Clonidine—glaucoma	0.0017	0.00256	CcSEcCtD
Dalfampridine—Headache—Latanoprost—glaucoma	0.0017	0.00256	CcSEcCtD
Dalfampridine—Skin disorder—Brinzolamide—glaucoma	0.0017	0.00255	CcSEcCtD
Dalfampridine—Confusional state—Pilocarpine—glaucoma	0.0017	0.00255	CcSEcCtD
Dalfampridine—Insomnia—Brimonidine—glaucoma	0.00169	0.00253	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.00168	0.00809	CbGpPWpGaD
Dalfampridine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00168	0.00252	CcSEcCtD
Dalfampridine—Paraesthesia—Brimonidine—glaucoma	0.00167	0.00251	CcSEcCtD
Dalfampridine—Infection—Pilocarpine—glaucoma	0.00167	0.00251	CcSEcCtD
Dalfampridine—Nausea—Methazolamide—glaucoma	0.00167	0.0025	CcSEcCtD
Dalfampridine—Hypotension—Dorzolamide—glaucoma	0.00166	0.0025	CcSEcCtD
Dalfampridine—Dyspnoea—Brimonidine—glaucoma	0.00166	0.0025	CcSEcCtD
Dalfampridine—Mental disorder—Clonidine—glaucoma	0.00166	0.00249	CcSEcCtD
Dalfampridine—Hypotension—Travoprost—glaucoma	0.00166	0.00249	CcSEcCtD
Dalfampridine—Dyspepsia—Brimonidine—glaucoma	0.00164	0.00247	CcSEcCtD
Dalfampridine—Hypotension—Brinzolamide—glaucoma	0.00164	0.00246	CcSEcCtD
Dalfampridine—Insomnia—Dorzolamide—glaucoma	0.00161	0.00242	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Brimonidine—glaucoma	0.00161	0.00242	CcSEcCtD
Dalfampridine—Feeling abnormal—Acetazolamide—glaucoma	0.0016	0.0024	CcSEcCtD
Dalfampridine—Hypersensitivity—Apraclonidine—glaucoma	0.0016	0.0024	CcSEcCtD
Dalfampridine—Paraesthesia—Dorzolamide—glaucoma	0.0016	0.0024	CcSEcCtD
Dalfampridine—Dyspnoea—Dorzolamide—glaucoma	0.00159	0.00238	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—NGFR—glaucoma	0.00158	0.00764	CbGpPWpGaD
Dalfampridine—Insomnia—Brinzolamide—glaucoma	0.00158	0.00238	CcSEcCtD
Dalfampridine—Dyspnoea—Travoprost—glaucoma	0.00158	0.00237	CcSEcCtD
Dalfampridine—Hypotension—Pilocarpine—glaucoma	0.00157	0.00236	CcSEcCtD
Dalfampridine—Paraesthesia—Brinzolamide—glaucoma	0.00157	0.00236	CcSEcCtD
Dalfampridine—KCNH5—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—SLC6A1—glaucoma	0.00157	0.00757	CbGpPWpGaD
Dalfampridine—Dyspepsia—Dorzolamide—glaucoma	0.00157	0.00235	CcSEcCtD
Dalfampridine—Dyspnoea—Brinzolamide—glaucoma	0.00156	0.00234	CcSEcCtD
Dalfampridine—Dyspepsia—Travoprost—glaucoma	0.00156	0.00234	CcSEcCtD
Dalfampridine—Asthenia—Apraclonidine—glaucoma	0.00156	0.00234	CcSEcCtD
Dalfampridine—Urticaria—Acetazolamide—glaucoma	0.00154	0.00232	CcSEcCtD
Dalfampridine—Tremor—Clonidine—glaucoma	0.00154	0.00232	CcSEcCtD
Dalfampridine—Dyspepsia—Brinzolamide—glaucoma	0.00154	0.00231	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Travoprost—glaucoma	0.00153	0.0023	CcSEcCtD
Dalfampridine—KCNS3—Neuronal System—SLC6A13—glaucoma	0.00153	0.00737	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—SLC6A13—glaucoma	0.00153	0.00737	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—SLC6A13—glaucoma	0.00153	0.00737	CbGpPWpGaD
Dalfampridine—Insomnia—Pilocarpine—glaucoma	0.00152	0.00229	CcSEcCtD
Dalfampridine—Constipation—Travoprost—glaucoma	0.00152	0.00228	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00151	0.00227	CcSEcCtD
Dalfampridine—Paraesthesia—Pilocarpine—glaucoma	0.00151	0.00227	CcSEcCtD
Dalfampridine—Asthenia—Bimatoprost—glaucoma	0.00151	0.00227	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—NTRK1—glaucoma	0.00151	0.00726	CbGpPWpGaD
Dalfampridine—Angioedema—Clonidine—glaucoma	0.0015	0.00226	CcSEcCtD
Dalfampridine—Dyspnoea—Pilocarpine—glaucoma	0.0015	0.00225	CcSEcCtD
Dalfampridine—Angiopathy—Betaxolol—glaucoma	0.00149	0.00224	CcSEcCtD
Dalfampridine—Immune system disorder—Betaxolol—glaucoma	0.00149	0.00223	CcSEcCtD
Dalfampridine—KCND3—Neuronal System—SLC6A13—glaucoma	0.00149	0.00717	CbGpPWpGaD
Dalfampridine—Mediastinal disorder—Betaxolol—glaucoma	0.00148	0.00223	CcSEcCtD
Dalfampridine—Dyspepsia—Pilocarpine—glaucoma	0.00148	0.00222	CcSEcCtD
Dalfampridine—Feeling abnormal—Dorzolamide—glaucoma	0.00147	0.0022	CcSEcCtD
Dalfampridine—Feeling abnormal—Travoprost—glaucoma	0.00146	0.00219	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00145	0.00218	CcSEcCtD
Dalfampridine—KCNB1—Neuronal System—SLC6A13—glaucoma	0.00145	0.00699	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Brinzolamide—glaucoma	0.00144	0.00217	CcSEcCtD
Dalfampridine—Mental disorder—Betaxolol—glaucoma	0.00144	0.00217	CcSEcCtD
Dalfampridine—Constipation—Pilocarpine—glaucoma	0.00144	0.00216	CcSEcCtD
Dalfampridine—Dizziness—Apraclonidine—glaucoma	0.00144	0.00216	CcSEcCtD
Dalfampridine—Urticaria—Dorzolamide—glaucoma	0.00141	0.00212	CcSEcCtD
Dalfampridine—Chest pain—Clonidine—glaucoma	0.0014	0.00211	CcSEcCtD
Dalfampridine—KCNA3—Neuronal System—SLC6A1—glaucoma	0.0014	0.00675	CbGpPWpGaD
Dalfampridine—Anxiety—Clonidine—glaucoma	0.0014	0.0021	CcSEcCtD
Dalfampridine—Asthenia—Acetazolamide—glaucoma	0.00139	0.00209	CcSEcCtD
Dalfampridine—Dizziness—Bimatoprost—glaucoma	0.00139	0.00209	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00139	0.00209	CcSEcCtD
Dalfampridine—Urticaria—Brinzolamide—glaucoma	0.00139	0.00209	CcSEcCtD
Dalfampridine—Feeling abnormal—Pilocarpine—glaucoma	0.00139	0.00208	CcSEcCtD
Dalfampridine—Vomiting—Apraclonidine—glaucoma	0.00138	0.00207	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—BDNF—glaucoma	0.00138	0.00665	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Brimonidine—glaucoma	0.00137	0.00206	CcSEcCtD
Dalfampridine—Dermatitis—Apraclonidine—glaucoma	0.00137	0.00205	CcSEcCtD
Dalfampridine—Headache—Apraclonidine—glaucoma	0.00136	0.00204	CcSEcCtD
Dalfampridine—Confusional state—Clonidine—glaucoma	0.00135	0.00203	CcSEcCtD
Dalfampridine—Tremor—Betaxolol—glaucoma	0.00134	0.00202	CcSEcCtD
Dalfampridine—Asthenia—Brimonidine—glaucoma	0.00134	0.00201	CcSEcCtD
Dalfampridine—KCNQ4—Neuronal System—SLC6A1—glaucoma	0.00133	0.00644	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—SLC6A1—glaucoma	0.00133	0.00644	CbGpPWpGaD
Dalfampridine—Infection—Clonidine—glaucoma	0.00133	0.002	CcSEcCtD
Dalfampridine—Rash—Bimatoprost—glaucoma	0.00133	0.00199	CcSEcCtD
Dalfampridine—Dermatitis—Bimatoprost—glaucoma	0.00133	0.00199	CcSEcCtD
Dalfampridine—KCNQ1—Neuronal System—SLC6A13—glaucoma	0.00133	0.00639	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—SLC6A13—glaucoma	0.00133	0.00639	CbGpPWpGaD
Dalfampridine—Connective tissue disorder—Timolol—glaucoma	0.00132	0.00199	CcSEcCtD
Dalfampridine—Headache—Bimatoprost—glaucoma	0.00132	0.00198	CcSEcCtD
Dalfampridine—Nervous system disorder—Clonidine—glaucoma	0.00132	0.00198	CcSEcCtD
Dalfampridine—Hypersensitivity—Dorzolamide—glaucoma	0.00131	0.00197	CcSEcCtD
Dalfampridine—Hypersensitivity—Travoprost—glaucoma	0.00131	0.00196	CcSEcCtD
Dalfampridine—Skin disorder—Clonidine—glaucoma	0.0013	0.00196	CcSEcCtD
Dalfampridine—KCNH6—Neuronal System—SLC6A13—glaucoma	0.0013	0.00627	CbGpPWpGaD
Dalfampridine—Nausea—Apraclonidine—glaucoma	0.00129	0.00194	CcSEcCtD
Dalfampridine—Hypersensitivity—Brinzolamide—glaucoma	0.00129	0.00194	CcSEcCtD
Dalfampridine—Dizziness—Acetazolamide—glaucoma	0.00128	0.00193	CcSEcCtD
Dalfampridine—Asthenia—Dorzolamide—glaucoma	0.00128	0.00192	CcSEcCtD
Dalfampridine—Asthenia—Travoprost—glaucoma	0.00127	0.00191	CcSEcCtD
Dalfampridine—Asthenia—Brinzolamide—glaucoma	0.00126	0.00189	CcSEcCtD
Dalfampridine—Hypotension—Clonidine—glaucoma	0.00126	0.00189	CcSEcCtD
Dalfampridine—Nausea—Bimatoprost—glaucoma	0.00125	0.00188	CcSEcCtD
Dalfampridine—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—glaucoma	0.00124	0.00599	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Pilocarpine—glaucoma	0.00124	0.00186	CcSEcCtD
Dalfampridine—Vomiting—Acetazolamide—glaucoma	0.00123	0.00186	CcSEcCtD
Dalfampridine—Dizziness—Brimonidine—glaucoma	0.00123	0.00185	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—NGF—glaucoma	0.00122	0.0059	CbGpPWpGaD
Dalfampridine—Angiopathy—Timolol—glaucoma	0.00122	0.00183	CcSEcCtD
Dalfampridine—Chest pain—Betaxolol—glaucoma	0.00122	0.00183	CcSEcCtD
Dalfampridine—Headache—Acetazolamide—glaucoma	0.00122	0.00183	CcSEcCtD
Dalfampridine—Anxiety—Betaxolol—glaucoma	0.00122	0.00183	CcSEcCtD
Dalfampridine—Insomnia—Clonidine—glaucoma	0.00121	0.00183	CcSEcCtD
Dalfampridine—Immune system disorder—Timolol—glaucoma	0.00121	0.00182	CcSEcCtD
Dalfampridine—Mediastinal disorder—Timolol—glaucoma	0.00121	0.00182	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.00121	0.00182	CcSEcCtD
Dalfampridine—Asthenia—Pilocarpine—glaucoma	0.00121	0.00181	CcSEcCtD
Dalfampridine—Paraesthesia—Clonidine—glaucoma	0.00121	0.00181	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.0012	0.00579	CbGpPWpGaD
Dalfampridine—Dyspnoea—Clonidine—glaucoma	0.0012	0.0018	CcSEcCtD
Dalfampridine—Confusional state—Betaxolol—glaucoma	0.00118	0.00177	CcSEcCtD
Dalfampridine—Mental disorder—Timolol—glaucoma	0.00118	0.00177	CcSEcCtD
Dalfampridine—Dizziness—Dorzolamide—glaucoma	0.00118	0.00177	CcSEcCtD
Dalfampridine—Rash—Brimonidine—glaucoma	0.00118	0.00177	CcSEcCtD
Dalfampridine—KCNA1—Neuronal System—SLC6A13—glaucoma	0.00118	0.00567	CbGpPWpGaD
Dalfampridine—Dermatitis—Brimonidine—glaucoma	0.00117	0.00176	CcSEcCtD
Dalfampridine—Dizziness—Travoprost—glaucoma	0.00117	0.00176	CcSEcCtD
Dalfampridine—Headache—Brimonidine—glaucoma	0.00117	0.00175	CcSEcCtD
Dalfampridine—Infection—Betaxolol—glaucoma	0.00116	0.00175	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Clonidine—glaucoma	0.00116	0.00174	CcSEcCtD
Dalfampridine—KCNH7—Neuronal System—SLC6A13—glaucoma	0.00116	0.00559	CbGpPWpGaD
Dalfampridine—Dizziness—Brinzolamide—glaucoma	0.00116	0.00174	CcSEcCtD
Dalfampridine—Nausea—Acetazolamide—glaucoma	0.00115	0.00173	CcSEcCtD
Dalfampridine—Constipation—Clonidine—glaucoma	0.00115	0.00173	CcSEcCtD
Dalfampridine—Nervous system disorder—Betaxolol—glaucoma	0.00115	0.00172	CcSEcCtD
Dalfampridine—Skin disorder—Betaxolol—glaucoma	0.00114	0.00171	CcSEcCtD
Dalfampridine—Vomiting—Dorzolamide—glaucoma	0.00113	0.0017	CcSEcCtD
Dalfampridine—Rash—Dorzolamide—glaucoma	0.00112	0.00169	CcSEcCtD
Dalfampridine—Dermatitis—Dorzolamide—glaucoma	0.00112	0.00168	CcSEcCtD
Dalfampridine—KCNG2—Neuronal System—SLC6A1—glaucoma	0.00112	0.0054	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—SLC6A1—glaucoma	0.00112	0.0054	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—SLC6A1—glaucoma	0.00112	0.0054	CbGpPWpGaD
Dalfampridine—Rash—Travoprost—glaucoma	0.00112	0.00168	CcSEcCtD
Dalfampridine—Dermatitis—Travoprost—glaucoma	0.00112	0.00168	CcSEcCtD
Dalfampridine—Headache—Dorzolamide—glaucoma	0.00112	0.00168	CcSEcCtD
Dalfampridine—Vomiting—Brinzolamide—glaucoma	0.00111	0.00167	CcSEcCtD
Dalfampridine—Dizziness—Pilocarpine—glaucoma	0.00111	0.00167	CcSEcCtD
Dalfampridine—Headache—Travoprost—glaucoma	0.00111	0.00167	CcSEcCtD
Dalfampridine—Nausea—Brimonidine—glaucoma	0.00111	0.00166	CcSEcCtD
Dalfampridine—Feeling abnormal—Clonidine—glaucoma	0.00111	0.00166	CcSEcCtD
Dalfampridine—Rash—Brinzolamide—glaucoma	0.0011	0.00166	CcSEcCtD
Dalfampridine—Dermatitis—Brinzolamide—glaucoma	0.0011	0.00166	CcSEcCtD
Dalfampridine—Headache—Brinzolamide—glaucoma	0.0011	0.00165	CcSEcCtD
Dalfampridine—Hypotension—Betaxolol—glaucoma	0.00109	0.00164	CcSEcCtD
Dalfampridine—KCND3—Neuronal System—SLC6A1—glaucoma	0.00109	0.00525	CbGpPWpGaD
Dalfampridine—Angioedema—Timolol—glaucoma	0.00107	0.00161	CcSEcCtD
Dalfampridine—Vomiting—Pilocarpine—glaucoma	0.00107	0.00161	CcSEcCtD
Dalfampridine—Urticaria—Clonidine—glaucoma	0.00107	0.0016	CcSEcCtD
Dalfampridine—Rash—Pilocarpine—glaucoma	0.00106	0.00159	CcSEcCtD
Dalfampridine—KCNB1—Neuronal System—SLC6A1—glaucoma	0.00106	0.00512	CbGpPWpGaD
Dalfampridine—Dermatitis—Pilocarpine—glaucoma	0.00106	0.00159	CcSEcCtD
Dalfampridine—Insomnia—Betaxolol—glaucoma	0.00106	0.00159	CcSEcCtD
Dalfampridine—Nausea—Dorzolamide—glaucoma	0.00106	0.00159	CcSEcCtD
Dalfampridine—Headache—Pilocarpine—glaucoma	0.00105	0.00158	CcSEcCtD
Dalfampridine—Nausea—Travoprost—glaucoma	0.00105	0.00158	CcSEcCtD
Dalfampridine—Paraesthesia—Betaxolol—glaucoma	0.00105	0.00158	CcSEcCtD
Dalfampridine—Dyspnoea—Betaxolol—glaucoma	0.00104	0.00157	CcSEcCtD
Dalfampridine—Nausea—Brinzolamide—glaucoma	0.00104	0.00156	CcSEcCtD
Dalfampridine—Dyspepsia—Betaxolol—glaucoma	0.00103	0.00155	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Betaxolol—glaucoma	0.00101	0.00152	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—BAD—glaucoma	0.00101	0.00487	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CA5A—glaucoma	0.001	0.00484	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CA5A—glaucoma	0.001	0.00484	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NARFL—glaucoma	0.001	0.00484	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CA5A—glaucoma	0.001	0.00484	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NARFL—glaucoma	0.001	0.00484	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NARFL—glaucoma	0.001	0.00484	CbGpPWpGaD
Dalfampridine—Constipation—Betaxolol—glaucoma	0.001	0.0015	CcSEcCtD
Dalfampridine—Nausea—Pilocarpine—glaucoma	0.000999	0.0015	CcSEcCtD
Dalfampridine—Chest pain—Timolol—glaucoma	0.000997	0.0015	CcSEcCtD
Dalfampridine—Anxiety—Timolol—glaucoma	0.000993	0.00149	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.00099	0.00149	CcSEcCtD
Dalfampridine—Hypersensitivity—Clonidine—glaucoma	0.00099	0.00149	CcSEcCtD
Dalfampridine—KCNQ3—Neuronal System—SLC6A13—glaucoma	0.000985	0.00475	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—SLC6A13—glaucoma	0.000985	0.00475	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—SLC6A1—glaucoma	0.00097	0.00468	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—SLC6A1—glaucoma	0.00097	0.00468	CbGpPWpGaD
Dalfampridine—Asthenia—Clonidine—glaucoma	0.000964	0.00145	CcSEcCtD
Dalfampridine—Feeling abnormal—Betaxolol—glaucoma	0.000964	0.00145	CcSEcCtD
Dalfampridine—Confusional state—Timolol—glaucoma	0.000963	0.00145	CcSEcCtD
Dalfampridine—Anaphylactic shock—Timolol—glaucoma	0.000955	0.00144	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—CA5A—glaucoma	0.000952	0.00459	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NARFL—glaucoma	0.000952	0.00459	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—SLC6A1—glaucoma	0.000951	0.00459	CbGpPWpGaD
Dalfampridine—Infection—Timolol—glaucoma	0.000949	0.00143	CcSEcCtD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—IL1A—glaucoma	0.000946	0.00456	CbGpPWpGaD
Dalfampridine—Nervous system disorder—Timolol—glaucoma	0.000937	0.00141	CcSEcCtD
Dalfampridine—Urticaria—Betaxolol—glaucoma	0.000929	0.0014	CcSEcCtD
Dalfampridine—Skin disorder—Timolol—glaucoma	0.000928	0.00139	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000896	0.00432	CbGpPWpGaD
Dalfampridine—Hypotension—Timolol—glaucoma	0.000893	0.00134	CcSEcCtD
Dalfampridine—CYP2E1—Tamoxifen metabolism—CYP1B1—glaucoma	0.000892	0.0043	CbGpPWpGaD
Dalfampridine—Dizziness—Clonidine—glaucoma	0.000888	0.00133	CcSEcCtD
Dalfampridine—Insomnia—Timolol—glaucoma	0.000864	0.0013	CcSEcCtD
Dalfampridine—Hypersensitivity—Betaxolol—glaucoma	0.000862	0.00129	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000861	0.00415	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—SLC6A1—glaucoma	0.00086	0.00415	CbGpPWpGaD
Dalfampridine—Paraesthesia—Timolol—glaucoma	0.000858	0.00129	CcSEcCtD
Dalfampridine—Vomiting—Clonidine—glaucoma	0.000854	0.00128	CcSEcCtD
Dalfampridine—Dyspnoea—Timolol—glaucoma	0.000852	0.00128	CcSEcCtD
Dalfampridine—KCNH7—Neuronal System—SLC6A1—glaucoma	0.000848	0.00409	CbGpPWpGaD
Dalfampridine—Rash—Clonidine—glaucoma	0.000847	0.00127	CcSEcCtD
Dalfampridine—Dermatitis—Clonidine—glaucoma	0.000846	0.00127	CcSEcCtD
Dalfampridine—Headache—Clonidine—glaucoma	0.000842	0.00126	CcSEcCtD
Dalfampridine—KCND2—Circadian rythm related genes—NGFR—glaucoma	0.000841	0.00406	CbGpPWpGaD
Dalfampridine—Dyspepsia—Timolol—glaucoma	0.000841	0.00126	CcSEcCtD
Dalfampridine—Asthenia—Betaxolol—glaucoma	0.000839	0.00126	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Timolol—glaucoma	0.000825	0.00124	CcSEcCtD
Dalfampridine—KCNQ3—Axon guidance—NCK2—glaucoma	0.000817	0.00394	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—NCK2—glaucoma	0.000817	0.00394	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—NTRK1—glaucoma	0.000799	0.00386	CbGpPWpGaD
Dalfampridine—Nausea—Clonidine—glaucoma	0.000798	0.0012	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—NGF—glaucoma	0.000796	0.00384	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000792	0.00382	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Timolol—glaucoma	0.000787	0.00118	CcSEcCtD
Dalfampridine—Dizziness—Betaxolol—glaucoma	0.000773	0.00116	CcSEcCtD
Dalfampridine—Urticaria—Timolol—glaucoma	0.000759	0.00114	CcSEcCtD
Dalfampridine—Vomiting—Betaxolol—glaucoma	0.000744	0.00112	CcSEcCtD
Dalfampridine—Rash—Betaxolol—glaucoma	0.000737	0.00111	CcSEcCtD
Dalfampridine—Dermatitis—Betaxolol—glaucoma	0.000737	0.00111	CcSEcCtD
Dalfampridine—KCNH7—Circadian rythm related genes—NGFR—glaucoma	0.000735	0.00355	CbGpPWpGaD
Dalfampridine—Headache—Betaxolol—glaucoma	0.000733	0.0011	CcSEcCtD
Dalfampridine—KCNQ2—Neuronal System—SLC6A1—glaucoma	0.000721	0.00348	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—SLC6A1—glaucoma	0.000721	0.00348	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Timolol—glaucoma	0.000704	0.00106	CcSEcCtD
Dalfampridine—KCNH7—Circadian rythm related genes—NTRK1—glaucoma	0.000699	0.00337	CbGpPWpGaD
Dalfampridine—Nausea—Betaxolol—glaucoma	0.000695	0.00104	CcSEcCtD
Dalfampridine—Asthenia—Timolol—glaucoma	0.000685	0.00103	CcSEcCtD
Dalfampridine—Dizziness—Timolol—glaucoma	0.000632	0.000949	CcSEcCtD
Dalfampridine—KCND2—Circadian rythm related genes—FAS—glaucoma	0.000626	0.00302	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000621	0.003	CbGpPWpGaD
Dalfampridine—Vomiting—Timolol—glaucoma	0.000607	0.000913	CcSEcCtD
Dalfampridine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000607	0.00293	CbGpPWpGaD
Dalfampridine—Rash—Timolol—glaucoma	0.000602	0.000905	CcSEcCtD
Dalfampridine—Dermatitis—Timolol—glaucoma	0.000602	0.000904	CcSEcCtD
Dalfampridine—Headache—Timolol—glaucoma	0.000599	0.000899	CcSEcCtD
Dalfampridine—KCNQ2—Developmental Biology—NCK2—glaucoma	0.000583	0.00281	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NCK2—glaucoma	0.000583	0.00281	CbGpPWpGaD
Dalfampridine—Nausea—Timolol—glaucoma	0.000568	0.000853	CcSEcCtD
Dalfampridine—KCNH7—Circadian rythm related genes—FAS—glaucoma	0.000547	0.00264	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CA1—glaucoma	0.00049	0.00237	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CA1—glaucoma	0.00049	0.00237	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CA1—glaucoma	0.00049	0.00237	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—SLC6A13—glaucoma	0.00049	0.00237	CbGpPWpGaD
Dalfampridine—CYP2E1—Tryptophan metabolism—CYP1B1—glaucoma	0.000476	0.0023	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CTSA—glaucoma	0.000475	0.00229	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CTSA—glaucoma	0.000475	0.00229	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CTSA—glaucoma	0.000475	0.00229	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CA1—glaucoma	0.000465	0.00224	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CTSA—glaucoma	0.00045	0.00217	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CA2—glaucoma	0.000449	0.00216	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CA2—glaucoma	0.000449	0.00216	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CA2—glaucoma	0.000449	0.00216	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000444	0.00214	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CA2—glaucoma	0.000425	0.00205	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000385	0.00186	CbGpPWpGaD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00038	0.00183	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.00038	0.00183	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PAX6—glaucoma	0.000378	0.00182	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PAX6—glaucoma	0.000378	0.00182	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—SLC6A1—glaucoma	0.000359	0.00173	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000332	0.0016	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—TNF—glaucoma	0.000326	0.00157	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000319	0.00154	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TXN—glaucoma	0.000316	0.00152	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TXN—glaucoma	0.000316	0.00152	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TXN—glaucoma	0.000316	0.00152	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000312	0.00151	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TXN—glaucoma	0.0003	0.00145	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—NGF—glaucoma	0.000294	0.00142	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000293	0.00141	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTT1—glaucoma	0.000245	0.00118	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTT1—glaucoma	0.000245	0.00118	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTT1—glaucoma	0.000245	0.00118	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—TP53—glaucoma	0.000234	0.00113	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP2—glaucoma	0.000233	0.00112	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP2—glaucoma	0.000233	0.00112	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTT1—glaucoma	0.000232	0.00112	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTT1—glaucoma	0.000208	0.001	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—glaucoma	0.000205	0.000988	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP1B1—glaucoma	0.000195	0.000942	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP1B1—glaucoma	0.000195	0.000942	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ABCA1—glaucoma	0.000195	0.000942	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ABCA1—glaucoma	0.000195	0.000942	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP1B1—glaucoma	0.000195	0.000942	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ABCA1—glaucoma	0.000195	0.000942	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ABCA1—glaucoma	0.000185	0.000893	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP1B1—glaucoma	0.000185	0.000893	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP9—glaucoma	0.000175	0.000845	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP9—glaucoma	0.000175	0.000845	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP2—glaucoma	0.000166	0.000803	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP2—glaucoma	0.000166	0.000803	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP1B1—glaucoma	0.000166	0.0008	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP1B1—glaucoma	0.000164	0.000789	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—glaucoma	0.000157	0.000759	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—glaucoma	0.000157	0.000759	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTM1—glaucoma	0.000156	0.000753	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTM1—glaucoma	0.000156	0.000753	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTM1—glaucoma	0.000156	0.000753	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTM1—glaucoma	0.000148	0.000714	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CA5A—glaucoma	0.000146	0.000704	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NARFL—glaucoma	0.000146	0.000704	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000141	0.000678	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—MTHFR—glaucoma	0.000138	0.000665	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—MTHFR—glaucoma	0.000138	0.000665	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—MTHFR—glaucoma	0.000138	0.000665	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTM1—glaucoma	0.000133	0.00064	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTM1—glaucoma	0.000131	0.000631	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—MTHFR—glaucoma	0.000131	0.000631	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOE—glaucoma	0.000128	0.00062	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOE—glaucoma	0.000128	0.00062	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOE—glaucoma	0.000128	0.00062	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CAV1—glaucoma	0.000127	0.000614	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CAV1—glaucoma	0.000127	0.000614	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CAV1—glaucoma	0.000127	0.000614	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—glaucoma	0.000125	0.000603	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—glaucoma	0.000125	0.000603	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOE—glaucoma	0.000122	0.000587	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CAV1—glaucoma	0.000121	0.000582	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TNF—glaucoma	0.000121	0.000581	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—glaucoma	0.000112	0.000542	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—glaucoma	0.000112	0.000542	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TNF—glaucoma	9.63e-05	0.000464	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TNF—glaucoma	9.63e-05	0.000464	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NOS3—glaucoma	9.62e-05	0.000464	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NOS3—glaucoma	9.62e-05	0.000464	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NOS3—glaucoma	9.62e-05	0.000464	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NOS3—glaucoma	9.12e-05	0.00044	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS2—glaucoma	8.8e-05	0.000424	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS2—glaucoma	8.8e-05	0.000424	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS2—glaucoma	8.8e-05	0.000424	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS2—glaucoma	8.34e-05	0.000402	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CA1—glaucoma	7.13e-05	0.000344	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CTSA—glaucoma	6.9e-05	0.000333	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CA2—glaucoma	6.52e-05	0.000314	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TXN—glaucoma	4.59e-05	0.000222	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTT1—glaucoma	3.56e-05	0.000172	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCA1—glaucoma	2.84e-05	0.000137	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP1B1—glaucoma	2.84e-05	0.000137	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTM1—glaucoma	2.27e-05	0.000109	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTHFR—glaucoma	2e-05	9.67e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOE—glaucoma	1.87e-05	9e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CAV1—glaucoma	1.85e-05	8.92e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NOS3—glaucoma	1.4e-05	6.74e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS2—glaucoma	1.28e-05	6.17e-05	CbGpPWpGaD
